Creative Medical Technology Holdings, Inc. (CELZ) Financial Statements
Industry: Biological Products, (No Diagnostic Substances)
In fiscal 2025, Creative Medical Technology reported revenue of $6,000, down 45.5% from $11,000 the year before. Net income was -$6.0M (a -99916.8% net margin), or -$2.52 per diluted share. Gross margin was 63.4% and operating margin was -102380.2%. Operating activities generated -$5.9M of cash. At fiscal year end, Creative Medical Technology held $7.8M in total assets against $284,880 in total liabilities.
Open the full interactive Creative Medical Technology financials → Quarterly statements, key ratios, valuation history and price charts.
Creative Medical Technology Key Stats
| Share Price | $0.82 |
|---|---|
| Market Cap | $3.0M |
| Revenue YoY Growth | -45.5% |
| 52-Week Range | $0.65 – $5.59 |
| Shares Outstanding | 10.9 million (basic, 2022 Q4) |
Creative Medical Technology Income Statement
| FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|
| Revenue | $164,500 | $87,754 | $88,600 | $9,000 | $11,000 | $6,000 |
| Gross Profit | $113,904 | $39,805 | $60,109 | $5,400 | $6,600 | $3,806 |
| Operating Income | -$1.1M | -$3.1M | -$10.2M | -$5.6M | -$5.7M | -$6.1M |
| Pre-Tax Income | -$36.3M | $19.2M | -$10.1M | -$5.3M | -$5.5M | -$6.0M |
| Income Tax | $0 | $0 | $0 | $0 | $0 | $0 |
| Net Income | -$36.3M | $19.2M | -$10.1M | -$5.3M | -$5.5M | -$6.0M |
| Diluted EPS | -$650.00 | $56.10 | -$9.30 | — | -$3.71 | -$2.52 |
Creative Medical Technology Quarterly Results
| 2025 Q3 | 2025 Q4 | 2026 Q1 | 2026 Q2 | |
|---|---|---|---|---|
| Revenue | $0 | $3,000 | $0 | $0 |
| Net Income | -$1.2M | -$1.9M | -$1.4M | -$1.5M |
| Diluted EPS | -$0.48 | -$0.79 | -$0.38 | -$0.41 |
Creative Medical Technology Balance Sheet
| FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | $98,012 | $10.7M | — | — | — | — |
| Current Assets | $98,012 | $10.7M | $18.7M | $10.3M | $6.1M | $7.4M |
| Total Assets | $717,775 | $11.3M | $19.2M | $10.7M | $6.7M | $7.8M |
| Current Liabilities | $40.5M | $1.1M | $3.3M | $371,394 | $327,644 | $284,880 |
| Total Long-Term Debt | $1.3M | — | — | — | — | — |
| Total Liabilities | $40.5M | $1.1M | $3.3M | $371,394 | $327,644 | $284,880 |
| Shareholders' Equity | -$39.8M | $10.2M | $15.9M | $10.3M | $6.3M | $7.5M |
Creative Medical Technology Cash Flow Statement
| FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|
| Cash From Operations | -$434,556 | -$2.2M | -$7.8M | -$8.0M | -$5.3M | -$5.9M |
| Cash From Investing | -$250,000 | $0 | -$10.1M | $3.4M | $6.3M | -$50,500 |
| Cash From Financing | $693,920 | $12.8M | $15.5M | -$270,952 | $1.5M | $7.2M |
Figures from Creative Medical Technology's 10-K and 10-Q filings with the SEC, as of 2026-10-14. Fiscal years follow the company's own reporting calendar. EPS and share counts are adjusted for later stock splits. See the full Creative Medical Technology financials page for every line item.
Creative Medical Technology Company Profile
| Ticker | CELZ |
|---|---|
| Exchange | Nasdaq |
| Industry | Biological Products, (No Diagnostic Substances) |
| Headquarters | Phoenix, Arizona |
| Incorporated in | Nevada |
| Fiscal Year End | December 31 |
| SEC Filer Category | Non-accelerated filer, smaller reporting company |
| SEC CIK | 0001187953 |
Frequently Asked Questions
What was Creative Medical Technology's revenue in fiscal 2025?
Creative Medical Technology (CELZ) reported revenue of $6,000 for fiscal 2025.
What is Creative Medical Technology's annual revenue history?
Creative Medical Technology's annual revenue by fiscal year: 2020: $164,500; 2021: $87,754; 2022: $88,600; 2023: $9,000; 2024: $11,000; 2025: $6,000.
What was Creative Medical Technology's net income in fiscal 2025?
Creative Medical Technology reported net income of -$6.0M for fiscal 2025.
What was Creative Medical Technology's earnings per share (EPS) in fiscal 2025?
Creative Medical Technology's diluted EPS was -$2.52 for fiscal 2025 (adjusted for any later stock splits).
What was Creative Medical Technology's revenue last quarter?
In its most recent reported quarter (2026 Q2), Creative Medical Technology reported revenue of $0.
How many shares of Creative Medical Technology are outstanding?
Creative Medical Technology reported a weighted average of 10.9 million basic shares outstanding in 2022 Q4.
What is Creative Medical Technology's market cap?
Based on its latest closing price, Creative Medical Technology (CELZ) has a market capitalization of about $3.0M.
When does Creative Medical Technology's fiscal year end?
Creative Medical Technology's fiscal year end, as registered with the SEC, is December 31.
Where is Creative Medical Technology headquartered?
Creative Medical Technology lists its business address in Phoenix, Arizona in its SEC filings.
Creative Medical Technology Competitors & Similar Companies
See all 136 Biological Products, (No Diagnostic Substances) companies →